awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41149668-07403909-6EB6-4F0B-BF72-248AD40F7803
Q41149668-07403909-6EB6-4F0B-BF72-248AD40F7803
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41149668-07403909-6EB6-4F0B-BF72-248AD40F7803
Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.
P2860
Q41149668-07403909-6EB6-4F0B-BF72-248AD40F7803
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41149668-07403909-6EB6-4F0B-BF72-248AD40F7803
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5baa238dd5d87b7eb52fd931f57f2abaeaf803c8
P2860
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study.